M itochondria of adult cardiac myocytes are seemingly static, without apparent organelle fission and fusion. Nevertheless, interruption of mitochondrial fusion or fission pathways in cardiac myocytes provokes lethal cardiomyopathies. 1 To resolve this paradox, we proposed functioning of mitochondrial fusion and fission factors in mitophagy.
M itochondria of adult cardiac myocytes are seemingly static, without apparent organelle fission and fusion. Nevertheless, interruption of mitochondrial fusion or fission pathways in cardiac myocytes provokes lethal cardiomyopathies. 1 To resolve this paradox, we proposed functioning of mitochondrial fusion and fission factors in mitophagy. 2 Thus, mitofusin 2 comediates mitochondrial fusion with mitofusin 1, 3 but is also a mitochondrial receptor for the mitophagy effector, Parkin. 4, 5 A role for mitochondrial fission in mitophagy is less well defined. Three independent reports of cardiac myocyte-specific ablation of profission dynamin-related protein 1 (Drp1) described cardiomyopathy and abnormal mitophagy, Parkin-mediated mitophagy in the heart are uncertain because the germ-line Parkin knockout mouse has no baseline cardiac phenotype. [9] [10] [11] A different approach is required to define Parkin's role in normal and mitochondrial fission-defective hearts. Here, we determined how positive and negative regulation of cardiac myocyte Parkin affects the in vivo mouse heart and interrogated the role of Parkin-mediated mitophagy in the cardiomyopathy provoked by cardiac myocyte-specific ablation of Drp1. In normal hearts, Parkin-stimulated mitophagy is well tolerated and largely dispensable. However, Parkin is upregulated, stimulates mitophagy, and contributes to loss of mitochondria and cardiomyopathy in hearts defective in mitochondrial fission. These results reveal Parkin to be a stress-inducible factor with the potential to help or hurt the heart, depending on functional integrity of the mitophagy-mitochondrial dynamism interactome.
Methods
Detailed Methods are available in the Online Data Supplement.
Results

Parkin Is Upregulated in Mitochondrial FissionDefective Mouse Hearts
Interrupting mitochondrial fission by cardiac myocyte-specific Drp1 ablation induces cardiomyopathy with loss of mitochondria (Online Figure I) . 8 Parkin localization to, and mitophagy of, mitochondria in Drp1-deficient cultured mouse embryonic fibroblasts (MEFs) 8 suggested a role for Parkin. However, Parkin protein was not abundant in normal hearts (Online Figure II ) 4 and Parkin mRNA levels equate to <1 transcript per cell ( Figure 1A ). These low levels of Parkin challenge the notion that Parkin causes hyper-mitophagy in cardiac Drp1-deficiency unless Parkin is upregulated therein. Indeed, we observed ≈5-fold greater Parkin mRNA levels ( Figure 1B) , and anti-Parkin immunoblotting revealed massively increased myocardial Parkin ( Figure 1C ) after Drp1 ablation. Thus, myocardial Parkin protein increases out of proportion to Parkin-specific mRNA in hearts rendered defective for mitochondrial fission. To determine how increased Parkin affects hearts, we transgenically expressed human Parkin in mouse cardiac myocytes. As Parkin evokes mitophagy by translocating to, and polyubiquitinating membrane proteins of, mitochondria, 12, 13 we measured mitochondrial Parkin content and protein ubiquitination. Parkin was plentiful in the mitochondriaenriched 10 000g pellet fraction of Parkin transgenic hearts, and associated with mitochondrial protein polyubiquitination ( Figure 2A ). The autophagosomal protein microtubuleassociated protein 1 light chain 3 (LC3-II) and its docking protein p62/sequestosome 1 (SQSTM1) were likewise increased in mitochondria, indicating activation of mitophagy ( Figure 2A ). When followed to 30 weeks of age, there was no evidence for cardiac enlargement, contractile dysfunction ( Figure 2B and 2C; Online Figure III ), or any adverse mitochondrial effect of Parkin ( Figure 2D and 2E). Although heart phenotypes may emerge over greater time, increasing Parkin-activated mitophagy without provoking pathology in otherwise normal young adult mouse hearts.
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Parkin Ablation Has Minimal Effects on Adult Mouse Hearts
The above results are consistent with observations that Parkin overexpression in other cell types is tolerated, even protective. 14 Accordingly, Parkin upregulation cannot be the exclusive cause of dilated cardiomyopathy after cardiac myocyte Drp1 ablation. To test if Parkin upregulation is a contributory factor, while minimizing the potential for compensatory upregulation of Parkin-independent mitophagy pathways that occurs with germ-line Park2 deletion, 15, 16 we created cardiac myocyte-specific Parkin knockout mice.
Mice with Lox-P sites flanking exon 7 of the Park2 (Parkin) gene 17 were obtained from Lexicon Pharmaceuticals and bred to myh6-driven MER-Cre-MER ( Figure 3A) . Tamoxifen was administered to 8-week-old mice for cardiac myocyte-specific Park2 recombination. Cardiac Parkin-deficient mice exhibited no change in cardiac size, heart weight corrected for body weight, or left ventricular contractile function over 20 weeks ( Figure 3E ). Whereas absence of cardiac Parkin could prove to be detrimental with increasing age, within the current 20-week study it was not.
Concomitant Ablation of Parkin Delays the Cardiac Phenotype Caused by Drp1 Deficiency
As cardiac Parkin ablation had no deleterious effects on otherwise normal hearts, we assessed the scale of Parkin upregulation in Drp1 deficiency by concomitantly deleting the Drp1 and Parkin genes in adult mouse hearts ( Figure 4A 
Discussion
These results help resolve ambiguous results relating to mitochondrial quality control in mammalian hearts. Parkinmediated mitophagy acts as a stress-reactive pathway to remove damaged mitochondria as originally proposed by Huang et al, 18 but seems unnecessary to routinely maintain mitochondrial quality. Absence of a housekeeper function can explain normal hearts in mice systemically lacking Parkin. 11 Our work shows that Parkin-mediated hyper-mitophagy can contribute to cardiomyopathy, here induced by interrupting Drp1-mediated mitochondrial fission. In a perinatal cardiac Drp1-deficient model, Kageyama et al 6 observed mitophagy that was not prevented by germ-line Parkin deletion. Our results do not address Parkin's role in perinatal hearts, but strongly implicate Parkin in mitophagy induced by interrupting mitochondrial fission in adult hearts. The cardiac myocyte-specific Parkin-deficient and -overexpressing models developed for this project should prove useful for rigorous interrogations of Parkin-mediated mitophagy and mitochondrial clearance after other forms of cardiac stress, helping to better define the roles of Parkin-dependent and ROS-stimulated Parkin-independent mitochondrial quality control pathways.
These results provide in vivo support for Shirihai's concept that mitophagy and Drp1 are inextricably linked through the mechanism of asymmetrical mitochondrial fission. 19 This has ramifications for ongoing therapeutic efforts directed toward inhibiting mitochondrial fission in cardiac disease, 20 as inhibition of Drp1 may concomitantly stimulate Parkin-mediated mitochondrial removal, ultimately reducing mitochondrial content. 
What Is Known?
• Parkin is highly expressed in hearts.
• Parkin-mediated mitophagy eliminates unhealthy mitochondria segregated via asymmetrical mitochondrial fission.
• The role of Parkin-mediated mitophagy in hearts with defective mitochondrial fission is controversial.
What New Information Does This Article Contribute?
• Parkin is not constitutively expressed at high levels in normal hearts, but is abundant when upregulated after stress.
• In otherwise normal young hearts Parkin-mediated mitophagy is not intrinsically pathological.
• Parkin-mediated mitophagy is induced and contributes to cardiomyopathy in mitochondrial fission-deficient hearts.
Mitochondrial quality is essential to cardiac homeostasis. Damaged mitochondria can be selectively eliminated via Parkinmediated mitophagy, but the role of Parkin in hearts is unclear. We showed that Parkin is expressed at low levels in normal young adult hearts, but was induced in mitochondrial fission-deficient hearts. Forced activation of Parkin-mediated mitophagy was not intrinsically harmful, but it contributed to the cardiomyopathy evoked by mitochondrial fission deficiency. These findings uncover the interdependent relationship between Parkin-mediated mitophagy and mitochondrial fission, sounding a cautionary note for therapeutic efforts directed toward inhibiting mitochondrial fission factor dynamin-related protein 1 (Drp1).
Matkovich and Gerald W. Dorn II , individually and in combination, were bred with mice carrying a myh6 promoter-driven nuclear-directed modified estrogen receptor (MER)-Cre transgene 3 to achieve tamoxifen-inducible gene deletion. Tamoxifen was administered to 8 week old adult mice as previously described 4 . Cardiomyocyte-specific human Parkin overexpression was achieved using the myh6 promoter-driven doxycycline-suppressible ("tet-off") bitransgeic system 5 ; doxycycline was never administered to dames or pups, inducing transgene expression after birth 6 . M-mode echocardiography was performed on unsedated mice 4 ; controls were age-matched Drp1 loxp/loxp littermates, Drp1 loxp/loxp +Parkin loxp/loxp littermates with or without tamoxifen administration and tetracycline-controlled transactivator protein (tTA) transgenic mice. All experimental procedures were approved by the Washington University Institutional Animal Care and Use Committee.
RNA Expression Analysis
mRNA abundance of Parkin and associated mitophagy factors, mitochondrial dynamics factors, mitochondrial biogenesis factors, and representative cardiac-expressed genes were obtained by analyzing RNA sequence data on 25 normal adult FVB mouse hearts generated from this laboratory, available at NCBI GEO GSE55792 7 .
Parkin mRNA abundance was also measured by quantitative real-time PCR. Total RNAs were extracted from snap-frozen cardiac tissues with TRIzol (Invitrogen, 15596-026); single strand cDNA was generated using high-capacity cDNA reverse transcription kit with RNase inhibitor (Invitrogen, 4374966) following the manufacturer's protocol. RNA expression analysis was performed using Taqman qRT-PCR 2x master mix (Invitrogen, 4440038) with predesigned primer/probes sets for mouse Park2 (Mm00450187_m1) and GAPDH (Hs02758991_g1).
Western Blotting
Cardiac tissues were collected, snap-frozen in liquid nitrogen, and homogenized in either tissue extraction reagent (Invitrogen, FNN0071) or a homogenizing buffer (10 mM HEPES, 320 mM sucrose, 3 mM MgCl 2 and 1mM DTT), with protease inhibitor (Roche, 05892970001) and phosphatase inhibitor (Roche, 04906837001) as previously described 4 . Myocardial homogenates were collected from the supernatant after centrifugation at 3,800 xg, myocardial mitochondrial fractions were pelleted and resuspended after centrifugation at 10,000 xg, and myocardial cytosolic fractions were collected from the supernatant after centrifugation at 100,000 xg. Proteins were size-separated by 4-15% pre-cast gradient SDS-PAGE (BioRad, 456-1084 and 456-1086), transferred to PVDF membranes (GE Healthcare, 10600021), and blocked with phosphate-buffered saline (PBS, Invitrogen, 70011-069) containing 0.1% Tween-20 (Promega, H5152) plus 5% nonfat dry milk (Bio-Rad, 170-6404) and/or 5% bovine serum albumin (BSA, Santa Cruz Biotech, 9048-46-8) at room temperature for 1 hour, incubated with primary antibodies at room temperature for 2 hours followed by incubation with horseradish peroxidase (HRP) conjugated secondary antibodies at room temperature for 1 hour, and visualized using the ECL chemiluminescence reagent (Bio-Rad, 170-5060).
Antibodies
For western blotting, primary antibodies against Drp1 (1:1000, ab56788), GAPDH (1:3000, ab8245), p62 (1:1000, ab56416), LC3 I/II (1:1000, ab128025), COX IV (1:1000, ab14744) were from Abcam. Primary antibody against ubiquitin (1:100, sc-8017) was from Santa Cruz Biotechnology. Primary antibody against Parkin was from Cell Signaling Technology (1:1000, #2132). Horseradish peroxidase (HRP) conjugated secondary antibodies anti-mouse IgG (1:3000, cs7076) and anti-rabbit IgG (1:3000, cs7074) were from Cell Signaling Technology.
Histological Studies
Mouse heart tissues were fixed with 4% formaldehyde solution in PBS with or without prior transcardial perfusion. Paraffin-embedded tissues were sectioned at a thickness of 5 µm on a Leica RM2255 rotary microtome. The sections were de-paraffinized in xylene, rehydrated with a gradient (100-50%) of ethanol, and washed in distilled water. Masson's trichrome stain (Sigma, HT15, HT10132 & 34256) was performed according to the manufacturers' protocol. For Evans blue studies, mice were intraperitoneally administered 1% Evans blue dye (Sigma, E2129) solution in PBS at 1% volume relative (ml) to body mass (g) 20-24 h prior to tissue sampling 8 . The sections were stained with FITC conjugated-wheat germ agglutinin (Invitrogen, W834) at room temperature for 30 min before nuclear counterstaining with DAPI (Vector Laboratories, H-1200). Evans blue positive cardiomyocytes fluoresce in red.
Transmission Electron Microscopy
Mouse heart tissues were fixed with EM fixation buffer (4% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4). A Jeol electron microscope (JEM-1400, JEOL, Tokyo, Japan) at 800x -8,000x direct magnifications was used for ultrastructural examination of osmium tetroxide/uranyl acetate stained mouse heart thin sections (90 nm). Mitochondrial content (% of the areas taken by mitochondria compared to those of the cardiomyocytes) and individual mitochondrial size and aspect ratio were measured using ImageJ (NIH) on transmission electron microscopic images.
Isolation of Cardiac Mitochondria
Isolation of cardiac mitochondria used a modification of a published protocol 9 . Briefly, mouse hearts were minced, incubated with trypsin and then homogenized with a glass/teflon Potter Elvehjem homogenizer. The homogenates were centrifuged at 800 xg at 4 °C for 10 min. The supernatants were centrifuged at 8,000 xg at 4 °C for 10 min and the resulting supernatants were discarded. The pellet containing the mitochondria was washed and centrifuged at 8,000 xg at 4 °C for 10 min before resuspension for functional analyses. Mitochondrial protein concentration was colorimetrically measured using Bio-Rad protein assay dye reagent concentrate (Bio-Rad, 500-0006).
Mitochondrial Respiration
Respiratory activities of isolated mitochondria were assessed using a micro Clark-type electrode in a closed and magnetically stirred glass chamber as previously described 10 . Non-stimulated (-ADP) respiration (state 2) and ADP (Sigma, A2754)-stimulated respiration (state 3) were measured. Oligomycin (Sigma, 75351) was added to inhibit ATP synthesis.
Flow Cytometric Analyses of Isolated Mitochondria
Isolated mitochondria were stained with 200 nM MitoTracker Green (Invitrogen, M-7514), 2 µM of tetramethylrhodamine, ethyl ester (TMRE, Invitrogen, T-669), or 2.5 µM MitoSOX red (Invitrogen, M36008) at room temperature for 20 min and washed twice with PBS. Flow cytometric analyses of mitochondrial size (forward scatter, FSC), mitochondrial membrane potential (TMRE fluorescence intensity detected by PE channel), or mitochondrial superoxide level (MitoSOX red fluorescence intensity detected by PE channel) were performed on a BD LSR II Flow Cytometer (Becton Dickinson, San Jose, CA). Data are presented as histograms for, and as bar graphs of average signal intensity of ~50,000 ungated events.
Statistical Analysis
Data are reported as mean ± SEM, unless otherwise stated. Unpaired Student's t test or ANOVA with Tukey's comparison were used for paired and group comparisons, respectively. P<0.05 was defined as significant. 
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